Diagnostic performance of molecular and serological markers for hepatitis E virus and Toxoplasma gondii coinfection across gestation in HIV-positive pregnant women

Read full text Summarise with VIRAT
Authors: Peter Asaga Mac, Dorcas Bulus, James K. Makpo, A.B. Yako, Philomena Ehi Airiohuodion
Cited by: 0
References: 29

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Accurate identification of recent hepatitis E virus (HEV) and Toxoplasma gondii infections during pregnancy is essential for clinical management, yet diagnostic performance data in HIV-positive populations remain limited. We evaluated serological and molecular diagnostic approaches for detecting recent coinfection across gestation. METHODS: In a prospective cohort of 780 HIV-positive pregnant women (CD4 + 200-400 cells/µL) in central Nigeria, we performed serial HEV and T. gondii IgG/IgM testing using recomLine immunoblot assays. A validation subset (n = 80) underwent HEV RNA detection by RT-qPCR and T. gondii IgG avidity testing. Diagnostic performance was calculated using molecular and avidity markers as reference standards. RESULTS: HEV IgM demonstrated 100% sensitivity (34/34) and 69.6% specificity for detecting HEV RNA-positive viraemia, the latter reflecting post-viraemic IgM persistence rather than serological false positivity, with 100% negative predictive value. Among IgM-positive participants, 70.8% (34/48) had detectable HEV RNA (mean Ct 31.6 ± 1.8). T. gondii IgM showed 100% concordance with low/intermediate avidity results, achieving 100% sensitivity and specificity for recent infection classification. Coinfection incidence increased from 1.9 to 7.8 per 100 person-months across gestation (adjusted HR 4.12, 95% CI 2.47-6.87). Dual IgM-positive cases showed 80% molecular/avidity confirmation of recent coinfection. Coinfection was associated with substantially elevated risks of adverse foetomaternal outcomes, including preterm birth (aRR 2.89, 95% CI 1.94-4.31), low birth weight (aRR 3.12, 95% CI 2.18-4.47), and perinatal mortality (aRR 4.17, 95% CI 2.04-8.52), all p < 0.001. CONCLUSIONS: Serological screening shows a very high negative predictive value, which is helpful in ruling out recent infections of HEV and T. gondii in HIV-positive pregnant women. If IgM antibodies are found, further testing using molecular or avidity-based methods is necessary.

Fields of Study & Subjects

Hepatitis Viruses Studies and Epidemiology Toxoplasma gondii Research Studies Parasitic Infections and Diagnostics

Publication details

Journal / source
Journal of Infection and Public Health
Volume
19
Issue
5
Pages
103214–103214
Publication date
27 March 2026
Language
EN